Adela's blood test in development for 20 cancer types, built on reading DNA methylation across the whole genome; no peer-reviewed screening results yet.
Adela, founded on cell-free methylated DNA immunoprecipitation work from Princess Margaret Cancer Centre, is developing a test for 20 pre-selected cancer types (company release, 26 May 2026) alongside its residual disease test. The CAMPERR case-control study (NCT05366881) is training and validating the platform across 20 cancer types. The only performance reported is a company conference figure: an interim AACR 2023 training readout across 12 cancer types with an area under the curve of 0.94 (0.92 at stage I), without sensitivity or specificity. No peer-reviewed multi-cancer paper, regulatory status or price was found.
Enriches every methylated fragment of cell-free DNA without bisulphite conversion and classifies the genome-wide pattern, to detect cancer and tell cancer types apart.
1.Adela multi-cancer methylome test slips into a pocket on its target.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"Adela multi-cancer methylome test" OR ABSTRACT:"Adela multi-cancer methylome test" OR TITLE:"Adela" OR ABSTRACT:"Adela") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Adela multi-cancer methylome test, not a curated reading list.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares DNA methylation profiling, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares DNA methylation profiling, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/